Figma vs. UiPath: Which Technology Stock Is a Better Buy in 2026?

UiPath is favored over Figma for 2026 based on its profitability, improved outlook and lower valuation: FY2026 revenue rose 12.7% to nearly $1.6B, net income reached $282.3M (17.5% margin), and forward P/E is 15.9x versus Figma's 73.1x. Figma grew faster, with FY2025 revenue up about 41% to nearly $1.1B, but posted a roughly $1.3B net loss and faces more direct disruption risk from AI-native design tools. Both companies maintain strong liquidity and minimal leverage, though stock-based compensation materially inflates reported free-cash-flow measures.

Analysis

The apparent PATH valuation discount is investable only if automation demand is becoming an AI-adoption budget line rather than a legacy RPA line item. The key operating test over the next 1-3 quarters is net-new ARR growth and large-customer expansion: sustained mid-teens growth with stable gross margin would support multiple re-rating toward profitable infrastructure software peers, while merely meeting revenue targets through renewals would leave the stock value-trapped. Reported cash generation also requires adjustment for dilution; share-count growth, not headline FCF, should determine whether the earnings inflection is genuinely accruing to shareholders.

FIG has the superior growth-duration narrative but is exposed to a sharper asymmetry: AI-assisted product creation can expand seats and workflows, yet it can also lower the value of standalone design-tool pricing. Enterprise billing changes are a near-term monetization catalyst, but successful conversion could invite procurement scrutiny and seat rationalization. The more relevant competitive read-through is not ADBE's legacy Creative Cloud performance, but whether Adobe's enterprise distribution can bundle comparable collaboration and AI functionality at a lower incremental budget cost.

A relative long PATH/short FIG expresses the quality-versus-duration divergence without requiring a broad software call. Consensus appears too comfortable treating PATH's profitability as proof of durable pricing power; its concentrated enterprise base means even a small number of automation-program delays could create an abrupt bookings miss. Conversely, FIG's post-IPO volatility and SBC-adjusted economics make it unsuitable for a fundamental long until retention, paid-seat expansion, and dilution are independently established.

Key Decisions for Investors

• Initiate a 3-6 month long PATH / short FIG pair, dollar-neutral, only after confirming FIG borrow availability and liquidity. Target 15-25% relative return if PATH's next two reports sustain ARR acceleration and FIG's enterprise monetization produces margin or retention friction; exit if PATH large-customer ARR decelerates below low-teens or a major account loss is disclosed.
• Add PATH on post-earnings weakness only if guidance is maintained or raised and operating-margin improvement is not primarily driven by sales-and-marketing cuts. A 15.9x forward P/E leaves room for a 20-30% re-rating, but downside is material if bookings weaken; use a 12-15% stop from entry pending customer-concentration disclosure.
• Avoid treating FIG's reported free cash flow as valuation support until fully diluted share growth, recurring SBC, and retention by enterprise cohort are available. Set an alert for evidence of accelerating dilution or weaker net revenue retention; either would justify increasing the FIG short leg rather than initiating an outright long.
• Use ADBE as a competitive monitor rather than a primary position: improving Creative Cloud enterprise seat growth or AI bundle adoption would weaken the FIG premium thesis, while material design-workflow share losses would create a potential long FIG/short ADBE reversal signal over 6-18 months.